Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

Condition:   Acute Bacterial Skin and Skin Structure Infection Interventions:   Drug: Xydalba;   Drug: vancomycin, teicoplanin or daptomycin Sponsors:   Aziende Chimiche Riunite Angelini Francesco S.p.A;   Hippocrates Research Not yet recruiting

Source: ClinicalTrials.gov - March 6, 2020 Category: Research Source Type: clinical trials